Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Silencer™ Select MALAT1 Positive Control siRNA

Click to view available options
Quantity:
5 nmol
Description
The Silencer™ MALAT1 positive control is extensively validated and an ideal “test” siRNA for those just beginning siRNA experiments, because it is validated to work in multiple cell lines. Because it targets MALAT1 mRNA, many assays are available to measure its effects, including real-time RT-PCR.What are Silencer™ Select siRNAs?Silencer™ Select siRNAs incorporate the latest improvements in siRNA design, off-target effect prediction algorithms, and chemical modifications, to yield siRNAs with unrivalled efficacy, potency, and specificity. The result is fewer failed experiments due to poor silencing, and cleaner, more consistent phenotypic data.
- Premium-quality siRNA, highly purified and ready to use
- Functionally tested in several common cell lines
- Include Silencer™ Select modifications for enhanced specificity
- For use in human, mouse, and rat cells

Specifications
Specifications
Content And Storage | The siRNA is provided dried down in a single tube, along with Nuclease-free Water for resuspension, and should be stored at –20°C. |
Control Type | Positive Control |
RNAi Type | siRNA |
For Use With (Application) | Transfection, RNAi |
Label or Dye | Unconjugated |
Product Line | Silencer™ Select, Ambion™ |
Product Type | siRNA |
Purity | HPLC |
Quantity | 5 nmol |
Shipping Condition | Dry Ice |
Show More |
For Research Use Only. Not for use in diagnostic procedures.
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction